Sclerosing Agents 

FDA Approved Sclerosol® Intrapleural Aerosol - Product 1680


DOWNLOAD THE DATASHEET (pdf)

Sclerosol® Intrapleural Aerosol is FDA approved for the treatment of Recurrent Malignant Pleural Effusion in symptomatic patients.

Containing 4 grams of asbestos-free, brucite-free pharmaceutical grade sterile talc powder, Sclerosol® Intrapleural Aerosol is packed in a single use canister and has a 2.5 year shelf life.

Please refer to package insert for Sclerosol® Intrapleural Aerosol for information relating to indications, administration and clinical pharmacology. For detailed product information please download the specification sheet (PDF) .
Website design by: Tidal Media Group